MeMed raises $93 million to translate the immune system
The Israeli company recently received FDA approval for its MeMed BV test to help healthcare providers distinguish between bacterial and viral infections
Source: calcalistech.com
Kfir Oved News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kfir Oved. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Kfir Oved Today - Breaking & Trending Today
Medical tech firm MeMed nabs $93m investment to decode body's immune responses
Company's BV blood test to distinguish between bacterial and viral infections recently cleared by FDA; investors include Hong Kong's Horizons Ventures
Source: timesofisrael.com
Israeli diagnostics co MeMed raises $93m
MeMed's technology rapidly distinguishes bacterial and viral infections, and can predict which Covid-19 patients need drug treatment.
Source: globes.co.il
Groundbreaking Israeli diagnostic test gets FDA approval. The next challenge: selling it to America
MeMed's test, which takes 15 minutes, can determine whether an infection is bacterial or viral with one blood sample
Source: haaretz.com
MeMed Key® Wins Red Dot Award for High Design Quality
MeMed Key® Wins Red Dot Award for High Design Quality April 22, 2021 07:00 ET | Source: MeMed MeMed , 2021 -frog, a leading global design and strategy consultancy, part of Capgemini Invent, and MeMed, a pioneer in the field of host immune response technology are proud to announce that MeMed Key ® has received the Red Dot Award for Product Design 2021. MeMed Key ® is a cutting-edge technology platform that allows highly sensitive and rapid measurements of multiple proteins at the point of need, empowering physicians to better diagnose and manage their patients in mu...
Source: globenewswire.com